Ozempic (semaglutide) is listed on Australia's Pharmaceutical Benefits Scheme (PBS), but eligibility is restricted to people with type 2 diabetes who meet specific clinical criteria — it is not currently PBS-subsidised solely for weight loss. Australians seeking Ozempic for weight management will generally need to pay a private prescription price unless they also have a qualifying diabetes diagnosis.
What is Ozempic and why are Australians asking about it?
Ozempic is an injectable medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It was originally developed to help manage blood glucose levels in adults with type 2 diabetes, and it is manufactured by Novo Nordisk. In recent years, semaglutide has attracted considerable attention in Australia because of its effect on appetite and body weight, leading many people to research it through weight loss clinics and general practitioners.
The interest from Australians researching best weight loss clinics in Sydney and elsewhere has grown substantially, with many patients asking whether they can access Ozempic through the subsidised PBS pathway rather than paying full private prescription costs. Understanding the difference between the PBS-listed use and off-label or private use is essential before making any decisions.
Ozempic should not be confused with Wegovy, which contains the same active ingredient (semaglutide) at a higher approved dose and is indicated specifically for chronic weight management. The regulatory and subsidy situations for each product differ, and you should confirm the current status of both with your prescribing doctor or pharmacist.
How does the PBS work in Australia?
The Pharmaceutical Benefits Scheme is a federal government programme that subsidises the cost of a wide range of medicines for eligible Australian residents. Under the PBS, patients pay a co-payment up to a capped amount, with the government covering the remainder of the approved medicine's cost. The scheme is administered by the Department of Health and Aged Care and listings are updated regularly by the Pharmaceutical Benefits Advisory Committee (PBAC).
For a medicine to be subsidised through the PBS, it must first be recommended by the PBAC based on clinical evidence of safety, efficacy, and cost-effectiveness. A medicine can be listed for one specific indication but not another, even if prescribers use it off-label in clinical practice. You can search current PBS listings at (PBS - Pharmaceutical Benefits Scheme).
Is Ozempic currently on the PBS?
Yes, Ozempic has a PBS listing in Australia, but that listing applies specifically to the management of type 2 diabetes in adults who meet defined clinical criteria. The listing is not open-ended; prescribers must follow the restriction criteria set out by the PBS, which typically involve requirements around prior treatment history, HbA1c levels, and sometimes body mass index thresholds - though you should verify the precise current criteria directly on the PBS website, as these details can change following PBAC reviews.
You can check the current PBS listing, including any Authority Required restrictions, on the official PBS medicine search tool at (PBS - Pharmaceutical Benefits Scheme). The Therapeutic Goods Administration (TGA) maintains separate information about the approved indications for registered medicines at (TGA).
As of the time of writing in 2026, Ozempic is not PBS-listed for weight loss as a standalone indication for people without type 2 diabetes. This means most Australians approaching weight loss clinics primarily for obesity treatment will not qualify for a subsidised Ozempic prescription through the PBS pathway.
Who is eligible for PBS-subsidised Ozempic?
To access Ozempic at the PBS-subsidised price, a patient generally needs to:
- Have a confirmed diagnosis of type 2 diabetes - Be managed by an eligible prescriber (typically a general practitioner or endocrinologist) - Meet the clinical criteria set out in the PBS restriction for the relevant item, which may include requirements around prior diabetes therapy and clinical measurements
Because these criteria are subject to change following PBAC reviews, it is important to confirm your individual eligibility directly with your GP or specialist. Your doctor can check the current restriction details and submit an Authority prescription if you qualify.
Patients who do not have type 2 diabetes but who are seeking weight management support should ask their doctor about whether any alternative PBS-listed treatments exist for their situation, or whether a referral to a specialist weight loss clinic is appropriate. See our cost guide for an overview of what private weight loss treatment might involve financially.
What about Ozempic for weight loss without a diabetes diagnosis?
If you do not have type 2 diabetes, you cannot currently access Ozempic through the PBS for weight management alone. There are a few pathways available:
Private prescription. Your GP or an authorised prescriber at a weight loss clinic may be willing to prescribe Ozempic on a private (non-subsidised) basis if they consider it clinically appropriate. You would pay the full cost at the pharmacy, which can vary depending on the dose and the supplier. Wegovy. Semaglutide is also marketed as Wegovy for chronic weight management. You should ask your doctor whether Wegovy is registered and available in Australia, and what its current subsidy status is, as the regulatory position may differ from Ozempic. Compounded semaglutide. Some patients have sought compounded versions of semaglutide. The TGA has issued guidance on this area, and you should be cautious - only use medicines sourced through regulated, licensed channels. Check the TGA website at (TGA) for current guidance on compounded medicines.It is worth emphasising that no weight loss treatment guarantees specific outcomes. Speak with a registered health professional to understand whether any semaglutide product is appropriate for your individual circumstances.
How to find a qualified prescriber through a weight loss clinic
If you are considering Ozempic or a related GLP-1 medication through a weight loss clinic, it is important to ensure the clinic employs appropriately registered practitioners. In Australia, doctors must be registered with the Medical Board of Australia, which you can verify through the AHPRA practitioner register at (AHPRA).
Reputable weight loss clinics will conduct a thorough clinical assessment before recommending any prescription medicine. Be cautious of online services that appear to minimise the clinical assessment process or that do not involve a face-to-face or video consultation with a registered medical practitioner.
Our methodology explains how we evaluate and list weight loss clinics to help you find a credible provider.
What questions should you ask before starting Ozempic?
Before committing to any treatment plan involving Ozempic or semaglutide, consider asking:
- Am I eligible for PBS subsidy, and if not, what will the private cost be? - What are the known side effects and contraindications for my health profile? - How will my progress be monitored over time? - Is this clinic staffed by practitioners registered with AHPRA? - Are there alternative PBS-listed weight loss medicines I should consider first?
Your GP remains the most appropriate starting point for these conversations, and they can coordinate referrals to specialists or multidisciplinary weight loss programmes if needed. Information about Medicare-rebatable consultations can be found at (MBS Online).
---
FAQ
Q: Can I get Ozempic from a weight loss clinic without a diabetes diagnosis? A: A registered prescriber at a weight loss clinic may be able to prescribe Ozempic privately (without PBS subsidy) if they assess it as clinically appropriate for you. However, this is not a PBS-covered pathway for weight loss alone, so the full cost applies. Q: Does Medicare cover any weight loss consultations? A: Medicare may provide rebates for consultations with your GP or specialist as part of general healthcare, but rebates for specific weight management programmes vary. Check current Medicare item numbers at (MBS Online). Q: How do I check if a clinic's doctor is legitimately registered in Australia? A: Use the AHPRA online practitioner register at (AHPRA) to search for any doctor by name and confirm their registration status and any conditions on their practice. Q: Will the PBS ever subsidise Ozempic for obesity treatment alone? A: PBS listings depend on PBAC recommendations, which are based on submissions from manufacturers and clinical evidence reviews. Whether and when semaglutide-based products might be listed for obesity without diabetes is a matter for ongoing government processes. Monitor updates at (PBS) and (Department of Health and Aged Care).---
Sources
- Pharmaceutical Benefits Scheme (PBS) - Therapeutic Goods Administration (TGA) - AHPRA Registers of Practitioners - MBS Online - Department of Health and Aged Care
---
Information in this article is general only and not medical advice. Verify the details with the linked sources or an appropriately qualified Australian professional before relying on them.
Browse our independent directory at /best/.